Posaconazole,171228-49-2
- 品牌:absin
- 型号:abs813369-5mg
- 产地:中国
- 供应商:爱必信(上海)生物科技有限公司
- 供应商报价:¥869
- 标签:Posaconazole,171228-49-2、Posaconazole,171228-49-2价格、Posaconazole,171228-49-2厂家、Noxafil;泊沙康唑;SCH 56592、Absin、爱必信(上海)生物科技有限公司
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
YZ剂描述: 产品名称:Posaconazole 产品别名:泊沙康唑 英文别名:Noxafil;;SCH 56592 靶点:lanosterol 14α-demethylase ,CYP3A4 CAS:171228-49-2 纯度:>98% 外观:白色或类白色粉末 保存方法:store at -20℃ for one year(Powder); in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months. 描述: Posaconazole (Noxafil)是甾醇C14ɑ去甲基化酶YZ剂,IC50为0.25 nM。 溶解性:DMSO :93 mg/mL (132.7 mM) 体外研究: Posaconazole has potent trypanocidal activity. Amiodarone acts synergistically with Posaconazole. Posaconazole also affects and disrupts Ca2+ homeostasis in T. cruzi. Posaconazole blocks the biosynthesis of ergosterol, which is essential for parasite survival. Posaconazole has a clear, dose-dependent effect on proliferation of the epimastigote (extracellular) stages, with a minimal inhibitory concentration of 20 nM and an IC50 of 14 nM. Against the clinically relevant intracellular amastigote form of the parasite, Posaconazole is even more potent. Posaconazole has the minimal inhibitory concentration and IC50 values of 3 nM and 0.25 nM. Posaconazole is active against isolates of Candida and Aspergillus spp. that exhibit resistance to Fluconazole, Voriconazole, and Amphotericin B and is much more active than the other triazoles against zygomycetes. 体内研究:Treatment of infected animals with amiodarone alone reduces parasitemia, increases survival 60 days pi (0% for untreated controls vs 40% for amiodarone-treated animals) and, when given in combination with Posaconazole, delays the development of parasitemia. Coadministration of Posaconazole and Boost Plus increases drug exposure compared to the administration of Posaconazole alone in the fasted state. Food, particularly meals high in fat content, significantly increases Posaconazole bioavailability. Systemic exposure to Posaconazole increases 4- and 2.6-fold when it is consumed with a high-fat and nonfat meal, respectively. Posaconazole and Amiodarone may constitute an effective anti-T. cruzi therapy with low side effect. At twice-daily doses of ≥15 mg/kg of body weight, Posaconazole prolongs the survival of the mice and reduces tissue burden. 产品信息订购:
产品更多信息请进入爱必信网站咨询 |